Epac activation with 8CPT-AM induced RLC phosphorylation in the perfused hearts. حسب Yoshiki Ohnuki (576298)

الموضوعات:

Changes in AL (A) and SE (B) according to the treatment time estimation curve in patients given 0.125% atropine. حسب Zi-Rong Chen (9227618)

الموضوعات:

Flow diagram of the patient selection into the final analysis. حسب Zi-Rong Chen (9227618)

الموضوعات:

Patients’ demographics and clinical parameters. حسب Zi-Rong Chen (9227618)

الموضوعات:

Associations between demographic variables, In4_SED and SE changes at 6 and 12 months after 4_SED (<i><i>n</i></i> = 80). حسب Zi-Rong Chen (9227618)

الموضوعات:

Table 2 - Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study حسب Zi-Rong Chen (9227618)

الموضوعات:

Functional characterization of skinned myocardium prepared from Epac1TG. حسب Yoshiki Ohnuki (576298)

الموضوعات:

Effects of chronic ISO infusion on cardiac function in Epac1TG. حسب Yoshiki Ohnuki (576298)

الموضوعات:

(a to g) Administration of vitamin D3 increased serum phosphorus and triglycerides. حسب Vidya G. Bettada (22208808)

"…Analyses of serum cholesterol, HDL and triglycerides also showed a non-significant decrease in the serum HDL level upon treatment with 125 µg/Kg vitamin D3, but a noticeable increase in the serum triglyceride level was observed with 125 µg/Kg of vitamin D3.…"

Spearman’s correlation matrix of weather conditions, both mean (x̄) and maximum, against daily number of visits to the water trough, mean water intake per visit, and mean water int... حسب M. Jordana Rivero (14610947)

Blood Pressure and LDL-C During Follow-up. حسب Karl Ingard (22582091)

الموضوعات:

Median EQ-5D-3L index values during 5 years of follow-up. حسب Karl Ingard (22582091)

الموضوعات:

Baseline Characteristics of Included Patients. حسب Karl Ingard (22582091)

الموضوعات:

Subgroup Analysis of the Occurrence of Secondary Endpoints. حسب Karl Ingard (22582091)

الموضوعات:

Study flow chart. حسب Karl Ingard (22582091)

الموضوعات:

Kaplan-Meier curve of the primary outcome. حسب Karl Ingard (22582091)

الموضوعات:

Number of Patients Who Reached the Primary and Secondary Endpoints During Follow-up. حسب Karl Ingard (22582091)

الموضوعات:

Subgroup Analysis of the Occurrence of the Primary Endpoint and Its Components. حسب Karl Ingard (22582091)

الموضوعات:

Tetrandrine decreases Mtb antigen presentation. حسب Elham Karamooz (2584474)

Baseline patient characteristics. حسب Oscar F. C. van den Bosch (22184246)

الموضوعات: